W. James

发表

Growth inhibition and antimetastatic effect of antisense poly-DNP-RNA on human breast cancer cells.

J. H. Wang, K. Ru, S. Schmitt, 1999, Oncology research.

SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Research, 5, [181].

P. Klenerman, J. Knight, P. Simmonds, 2021 .

Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses

V. Balasubramaniam, W. James, N. Adnan, 2022, PLoS neglected tropical diseases.

Neutralizing Antibodies to SARS‐CoV‐2 Selected from a Human Antibody Library Constructed Decades Ago

R. Lerner, R. Dwek, N. Wu, 2021, Advanced science.

Host Molecules Regulating Neural Invasion of Zika Virus and Drug Repurposing Strategy

V. Balasubramaniam, W. James, Lindi Tan, 2022, Frontiers in Microbiology.

Human Dendritic Cells Chemokine Ligand 11) Receptor CCR3 by Expression of a Functional Eotaxin (CC

R. Steinman, D. Robbiani, M. Pope, 2002 .

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

Calliope A. Dendrou, P. Sopp, P. Klenerman, 2021, Nature immunology.

The 5 (cid:1) Leader of the mRNA Encoding the Marek’s Disease Virus Serotype 1 pp14 Protein Contains an Intronic Internal Ribosome Entry Site with Allosteric Properties (cid:1)

V. Mauro, Daiki Matsuda, V. Nair, 2009 .

SAMHD1 controls nucleoside-based cancer therapeutics, deoxyguanosine toxicity, and inflammation

M. D. Moore, Steven Johnson, Errin Johnson, 2022, bioRxiv.

Hide and Seek: The Interplay Between Zika Virus and the Host Immune Response

W. James, N. Adnan, Thamil Vaani Komarasamy, 2021, Frontiers in Immunology.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

P. Klenerman, T. Wrin, C. Petropoulos, 2021, Nature Communications.

Inhibition of heterologous strains of HIV by antisense RNA.

A. Rhodes, W. James, 1991, AIDS.

Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro.

W. James, S. Thompson, S. Thompson, 1993, Nucleic acids research.

Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.

P. Klenerman, E. Barnes, A. Pollard, 2021 .

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

P. Klenerman, S. Rowland-Jones, M. Haniffa, 2021, The Lancet Microbe.

1 Autoreactive pre-plasma cells break tolerance in the absence of regulation by dendritic cells and macrophages

S. Gauld, B. Vilen, V. Nickeleit, 2012 .

Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity

D. Stuart, P. Klenerman, J. Knight, 2021, Social Science Research Network.

Towards Gene-Inhibition Therapy: A Review of Progress and Prospects in the Field of Antiviral Antisense Nucleic Acids and Ribozymes

W. James, William James, 1991 .

Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA.

A. Rhodes, W. James, A. Rhodes, 1990, The Journal of general virology.

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern

Fan Zhou, R. Cox, S. Øyen, 2021, Communications Medicine.

Materials and Methods A 549 Cell Culture and Infection with Seasonal Influenza Viruses

Carrie W. Evans, K. Wennerberg, M. Patricelli, 2014 .

Cytotoxic T Lymphocyte Lysis Inhibited by Viable HIV Mutants

P. Klenerman, B. Larder, R. Phillips, 1995, Science.

An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

P. Sopp, P. Klenerman, N. Ashley, 2021, Nature Immunology.

Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2

D. Stuart, Che Ma, M. Carroll, 2022, Theranostics.

SARS-CoV-2 Variants, Vaccines, and Host Immunity

S. Gordon, A. Strydom, J. Mellet, 2022, Frontiers in Immunology.

Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences

Alfredo Castello, J. McKeating, M. Thompson, 2021, bioRxiv.

Zika Virus Neuropathogenesis: The Different Brain Cells, Host Factors and Mechanisms Involved

V. Balasubramaniam, W. James, N. Adnan, 2022, Frontiers in Immunology.

Gene Inhibition of HIV‐1 Replication.

A. Rhodes, W. James, P. Crisell, 1992, Annals of the New York Academy of Sciences.

Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences

Alfredo Castello, J. McKeating, M. Thompson, 2022, eLife.

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Alfredo Castello, P. Ratcliffe, J. McKeating, 2020, Cell Reports.

Hypoxia dampens innate immune signalling at early time points and increases Zika virus replication in iPSC-derived macrophages

J. McKeating, W. James, Mirjam Schilling, 2023, bioRxiv.

Maintained in Immature Anti-Insulin B Cells Functional Silencing Is Initiated and

Rachel A. Henry, Carlos A. Acevedo-Suárez, W James, 2013 .

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy

Joanne Sun, M. Knight, P. Rijal, 2020, mAbs.

Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases

Ross D. Cranston, B. Sproat, M. D. Moore, 2010, The Journal of Biological Chemistry.

Hypoxia dampens innate immune signalling at early time points and increases Zika virus RNA levels in iPSC-derived macrophages.

J. McKeating, W. James, Mirjam Schilling, 2023, The Journal of general virology.

Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides.

D. Bunka, P. Stockley, M. D. Moore, 2011, The Journal of general virology.

Pharmacological activation of the circadian component REV-ERB inhibits HIV-1 replication

P. Borrow, J. McKeating, P. Balfe, 2020, Scientific Reports.